Parker Laboratories, Inc.: Drug Recall
Recall #D-1092-2023 · 08/02/2023
Class II: Risk
Recall Details
- Recall Number
- D-1092-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Parker Laboratories, Inc.
- Status
- Terminated
- Date Initiated
- 08/02/2023
- Location
- Fairfield, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40
Reason for Recall
CGMP Deviations
Product Description
Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004
Distribution Pattern
Nationwide within the United States, Singapore, Korea and Hong Kong
Other Recalls by Parker Laboratories, Inc.
- Class II: Risk 08/02/2023
- Class II: Risk 08/02/2023
- Class II: Risk 08/02/2023
- Class II: Risk 08/02/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.